M1 Kliniken AG (M12.DE)
XETRA · EUR · Healthcare · Medical Distribution
€19.44 (-1.32%) as of
Key statistics
- Market cap
- 360.71M
- P/E (TTM)
- 18.87
- Forward P/E
- 17.36
- EPS (TTM)
- 1.03
- Dividend yield
- 6.19%
- 52-week range
- 13.62 – 21.70
- Beta
- 1.01
- Revenue (TTM)
- 257.36M
- Profit margin
- 7.86%
- Volume
- 759.00
About M1 Kliniken AG
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Headquarters
- Berlin, Germany
- Employees
- 280
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.